Hutch News

Hutch News

Stories tagged 'malaria'

Data drives life sciences boom in Seattle

Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference

March 30, 2018 | By Sabin Russell and Diane Mapes / Fred Hutch News Service

At a conference in Seattle, health researchers and entrepreneurs said partnerships are key as bioscience converges with data science and computer technology.

View story >


New antibody and unique binding site offer possible paths to malaria prevention

Led by NIH, Fred Hutch researchers, early study holds promise for direct infusion or vaccine design

March 19, 2018 | By Mary Engel / Fred Hutch News Service

Fred Hutch structural biologist Dr. Marie Pancera is seeking clues for designing a malaria vaccine by studying the differences between newly discovered antibodies that bind the same site on the malaria parasite.

View story >


Malaria during pregnancy can alter babies’ immunity

Mothers infected with the mosquito-borne parasite during pregnancy can pass more of their own cells to their offspring and change their babies’ risk of later infection, new study shows

May 8, 2017 | By Rachel Tompa / Fred Hutch News Service

A new study looks at how malaria can alter the mother-child cell sharing that happens during pregnancy — and how that cell sharing can affect the baby's risk of infection later in life.

View story >


On the path to a new-generation malaria vaccine

New approach using genetically modified parasite ‘primes the immune system’ in first human trial

Jan. 4, 2017 | By Mary Engel / Fred Hutch News Service

Volunteers in a clinical trial led by Fred Hutch's Dr. Jim Kublin endured 150 to 200 mosquito bites in one 10-minute session to test a new approach to a malaria vaccine that uses genetically attenuated, or weakened, parasites to stimulate an immune response to malaria without causing disease.

View story >


Getting malaria on purpose

Volunteers roll up their sleeves and get infected to test an experimental drug

April 25, 2016 | By Mary Engel / Fred Hutch News Service

Eight healthy adults ranging in age from 20 to 37 are taking part in a new study conducted by the Seattle Malaria Clinical Trials Center, run by Fred Hutchinson Cancer Research Center and the Center for Infectious Disease Research.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.